Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase 1/2 5Phase 1 5Phase NA 1Phase 4 1Phase 3 1

Status

Recruiting 3Completed 1Active not recruiting 1

Sponsor Class

OTHER 3NIH 2

Study Type

Interventional 5

Sponsor

Cancer Type

CNS 5Sarcoma 3Genitourinary 2Gastrointestinal 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 53Neoplasms 49Neoplasm Metastasis 44Colorectal Neoplasms 44Leukemia, Myeloid, Acute 42Breast Neoplasms 40Prostatic Neoplasms 36Multiple Myeloma 31Ovarian Neoplasms 29Recurrence 26Melanoma 24Lymphoma, Non-Hodgkin 24Squamous Cell Carcinoma of Head and Neck 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 23Pancreatic Neoplasms 23Triple Negative Breast Neoplasms 21Myelodysplastic Syndromes 21Endometrial Neoplasms 20Carcinoma, Renal Cell 18Stomach Neoplasms 17Small Cell Lung Carcinoma 17Lung Neoplasms 17Advanced Solid Tumors 17Carcinoma, Hepatocellular 15Brain Neoplasms 15Sarcoma 14Glioblastoma 14Esophageal Neoplasms 12Urinary Bladder Neoplasms 11Solid Tumors 11

Interventions

fludarabine phosphate 1fludarabine 1Temozolomide 1Mesna 1Irinotecan 1Interleukin-15 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1 × Neuroblastoma × 30 days × Clear all
NCT01875601 2026-05-22

NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
16 enrolled
CNSSarcoma

Brain Neoplasms, Neuroblastoma, Sarcoma

NCT06995872 2026-05-22

Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
40 enrolled
CNS

Neuroblastoma

NCT07172958 2026-05-22

SABRE

Children's National Research Institute

Phase 1 Recruiting
18 enrolled
CNSGenitourinarySarcoma

Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing

NCT02311621 2026-05-19

Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01

Seattle Children's Hospital

Phase 1 Active not recruiting
65 enrolled
CNS

Neuroblastoma, Ganglioneuroblastoma

NCT04897321 2026-05-19

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

St. Jude Children's Research Hospital

Phase 1 Recruiting
48 enrolled
CNSDermatologicGastrointestinalGenitourinarySarcoma

Adrenal Cortex Neoplasms, Carcinoma, Melanoma, Neoplasms, Germ Cell and Embryonal, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma, Sarcoma, Clear Cell, Neurofibrosarcoma, Rhabdoid Tumor, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡